Multinational generic pharmaceutical giant Teva reached a $420 million settlement with shareholders who claimed the company hid a price-fixing scheme and artificially inflated share prices. According to the suit, filed in federal court in Connecticut, the price-fixing...
Driven. Creative. Strategic. Focused.
